<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Because PI3K plays an important role in the regulation of ROS production by human neutrophils [
 <xref rid="B49-molecules-24-01809" ref-type="bibr" class="xref">49</xref>,
 <xref rid="B50-molecules-24-01809" ref-type="bibr" class="xref">50</xref>], we evaluated the effect of specific inhibitors of various PI3K isoforms on 1,3-dithiane-stimulated ROS production in neutrophils. Four PI3K inhibitors with different subtype specificities, including A-66, TGX 221, AS605240, and PI-3065 [
 <xref rid="B51-molecules-24-01809" ref-type="bibr" class="xref">51</xref>,
 <xref rid="B52-molecules-24-01809" ref-type="bibr" class="xref">52</xref>,
 <xref rid="B53-molecules-24-01809" ref-type="bibr" class="xref">53</xref>], were tested. PI-3065, a PI3K p110δ inhibitor, demonstrated the most potent inhibitory effect (IC
 <sub class="sub">50</sub> = 0.03 ± 0.01 µM). The other inhibitors had lower activity, as follows: TGX 221 (PI3K-β inhibitor, IC
 <sub class="sub">50</sub> = 0.10 ± 0.03 µM) &gt; AS 605240 (PI3Kγ inhibitor, IC
 <sub class="sub">50</sub> = 0.18 ± 0.04 µM) &gt;&gt; A66 (PI3K p110α inhibitor, IC
 <sub class="sub">50</sub> = 3.9 ± 1.2 µM) (
 <xref ref-type="fig" rid="molecules-24-01809-f002" class="xref">Figure 2</xref>A,C). 
</p>
